title: British Association of Dermatologists' guidelines for the safe and effective prescribing of methotrexate for skin disease 2016.
authors.affiliation: The Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, Manchester, M6 8HD, U.K.
authors.forename: R B
authors.initials: RB
authors.lastname: Warren
authors.affiliation: Department of Dermatology, Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, U.K.
authors.forename: S C
authors.initials: SC
authors.lastname: Weatherhead
authors.affiliation: St John's Institute of Dermatology, Guy's and St Thomas NHS Foundation Trust, London, SE1 9RT, U.K.
authors.forename: C H
authors.initials: CH
authors.lastname: Smith
authors.affiliation: British Association of Dermatologists, Willan House, 4 Fitzroy Square, London, W1T 5HQ, U.K.
authors.forename: L S
authors.initials: LS
authors.lastname: Exton
authors.affiliation: British Association of Dermatologists, Willan House, 4 Fitzroy Square, London, W1T 5HQ, U.K.
authors.forename: M F
authors.initials: MF
authors.lastname: Mohd Mustapa
authors.affiliation: St Vincent's University Hospital, Elm Park, Dublin, Ireland.
authors.forename: B
authors.initials: B
authors.lastname: Kirby
authors.affiliation: Glan Clwyd Hospital, Sarn Lane, Rhyl, LL18 5UJ, U.K.
authors.forename: P D
authors.initials: PD
authors.lastname: Yesudian
mesh_terms: D000328:Adult; D000428:Alcohol Drinking; D001688:Biological Products / Q000009:adverse effects; D001855:Bone Marrow Diseases / Q000139:chemically induced; D057189:Checklist; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D002644:Chickenpox / Q000150:complications; D002648:Child; D003376:Counseling / Q000379:methods; D016572:Cyclosporine / Q000009:adverse effects; D003879:Dermatologic Agents / Q000009:adverse effects / Q000506:poisoning / Q000627:therapeutic use*; D004333:Drug Administration Routes; D004334:Drug Administration Schedule; D017277:Drug Approval; D004347:Drug Interactions; D016903:Drug Monitoring / Q000379:methods; D062787:Drug Overdose / Q000209:etiology; D019317:Evidence-Based Medicine; D005260:Female; D015658:HIV Infections / Q000150:complications; D006525:Hepatitis, Viral, Human / Q000150:complications; D006801:Humans; D007431:Intraoperative Complications / Q000139:chemically induced; D007674:Kidney Diseases / Q000139:chemically induced; D008171:Lung Diseases / Q000139:chemically induced; D008727:Methotrexate / Q000009:adverse effects / Q000506:poisoning / Q000627:therapeutic use*; D009325:Nausea / Q000139:chemically induced; D009369:Neoplasms / Q000139:chemically induced; D056687:Off-Label Use; D010353:Patient Education as Topic / Q000379:methods; D061214:Patient Safety; D011247:Pregnancy; D011248:Pregnancy Complications / Q000517:prevention & control; D012176:Retinoids / Q000009:adverse effects; D012871:Skin Diseases / Q000188:drug therapy*; D014376:Tuberculosis / Q000150:complications; D014466:Ultraviolet Rays / Q000009:adverse effects; D014611:Vaccination / Q000009:adverse effects
chemical_list: D001688:Biological Products; D003879:Dermatologic Agents; D012176:Retinoids; D016572:Cyclosporine; D008727:Methotrexate